| Autor: |
Mercadal S; Utah Transplant and Cellular Therapy Program, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT., Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Allbee-Johnson M; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI., Ganguly S; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY; Section of Hematology, Houston Methodist Hospital and Neal Cancer Center, Houston, TX., Geethakumari PR; Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX., Hong S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC., Malone A; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY., Murthy H; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL., Pawarode A; Division of Hematology/Oncology, Department of Internal Medicine, Blood and Marrow Transplantation Program, University of Michigan Medical School, Ann Arbor, MI., Sica AR; Department of Hematology-Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY., Solh M; Blood and Marrow Transplant Program, Northside Hospital, Atlanta, GA., Ustun C; Rush University Medical Center, Chicago, IL., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Sauter CS; Hematology/Medical Oncology, Cleveland Clinic, Cleveland, OH., Hamadani M; BMT and Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI. mhamadani@mcw.edu., Herrera AF; City of Hope, Duarte, CA., Lee CJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA. |
